- Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation. Sagrada, A., Turconi, M., Bonali, P., Schiantarelli, P., Micheletti, R., Montagna, E., Nicola, M., Algate, D.R., Rimoldi, E.M., Donetti, A. Cancer Chemother. Pharmacol. (1991)









